Expiration of Reference drug during Bioanalysis [Bioanalytics]
» is there any guidance which I can refer to in this point?
For your specific case, none I’m aware of. But:
- It is acceptable to give a drug on the very last day of its shelf life to patients. Hence, the same is applicable in a BE study.
- Once the drug is in the circulation only the stability in matrix is relevant. The parent/metabolite(s) don’t “know” whats happening to the formulation.
- For my analogy of expired reference standards see the FDA’s drafted BMV guidance Section III.B.1.a.
That’s similar: If the stability of a stock solution is validated you can still use it, although the reference might have expired in the meantime.
Logic behind: When you weighed the standard in, it was within its shelf life and therefore, the concentration of the stock solution correct. The drug in the stock solution doesn’t “care” that the standard expired.
The quality of responses received is directly proportional to the quality of the question asked. ☼
- Expiration of Reference drug during Bioanalysis wienui 2019-04-14 11:51 [Bioanalytics]
- Expiration of Reference drug during Bioanalysis Helmut 2019-04-14 12:56
- Expiration of Reference drug during Bioanalysis jag009 2019-04-15 06:51
- Expiration of Reference drug during Bioanalysis wienui 2019-04-15 20:58